Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
FDA First Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies Noted for Suicidal Bipolar Depression Treatment from NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Tickers NRXP
Exposures Product Safety
News headline image
Trump’s FDA Pick Heidi Overton Faces Republican Resistance as Bill Cassidy Calls Vaccine Order Role ‘Almost Disqualifying’ ↗
Via Benzinga
Topics Government
Exposures Political Product Safety
News headline image
Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Clene Eyes Q4 NDA for ALS Drug After FDA-Requested Biomarker Analyses ↗
Via MarketBeat
Tickers CLNN
Exposures Product Safety
News headline image
Longeveron (LGVN) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property
Tickers LGVN
Exposures Financial Intellectual Property Product Safety
News headline image
Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma Data ↗
Via The Motley Fool
Topics Stocks
Tickers MRNA PFE
Exposures Product Safety US Equities
News headline image
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Via Newsfile
Topics Lawsuit
Tickers CAPR SAP
Exposures Financial Legal Product Safety
News headline image
Guangdong Aodai: A Benchmark for Color-Cosmetic Manufacturing in South China, Empowering Global Beauty Brands With Full Industry-Chain Capabilities
Via AB Newswire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Product Safety Supply Chain
News headline image
Femasys Secures FDA Pathway for Non-Surgical Contraceptive ↗
Via Benzinga
Exposures Product Safety
News headline image
What's Going On With Becton Dickinson Stock Wednesday? ↗
Via Benzinga
Exposures Product Safety
News headline image
Johnson & Johnson Expands Robotic Bronchoscopy Push With AI, 3D Navigation Upgrade ↗
Via Benzinga
Topics Artificial Intelligence
Tickers JNJ
Exposures Artificial Intelligence Product Safety
News headline image
IceCure Medical (ICCM) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers ICCM
Exposures Financial Product Safety
News headline image
PolyPid (PYPD) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers PYPD
Exposures Financial Product Safety
News headline image
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (MDLN) Investors to Contact the Firm
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
News headline image
INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit: Investors Face September 28, 2026, Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Receives Canadian Patent Allowance for Lead Asset SPC-15
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Tickers SILO
Exposures Artificial Intelligence Intellectual Property Product Safety
News headline image
Humacyte (HUMA) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers HUMA
Exposures Financial Product Safety
News headline image
LENZ Therapeutics (LENZ) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers LENZ
Exposures Financial Product Safety
News headline image
BridgeBio (BBIO) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers BBIO
Exposures Financial Product Safety
Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves
Via Investor Brand Network
Tickers CSE:QNTM QNTM
Exposures Product Safety
News headline image
Buy MTP Kit Online USA: Secure Payment, Safe Ordering Guide & What to Know ↗
Via Talk Markets
Exposures Product Safety
News headline image
Electrosurgical Devices Market Size, Trends, and Strategic Outlook 2026-2033 ↗
Via Talk Markets
Topics Economy Supply Chain World Trade
Exposures Product Safety Supply Chain Tariff
News headline image
Trump Picks White House Health Adviser Heidi Overton to Lead FDA After Marty Makary’s Exit ↗
Via Benzinga
Topics Government
Exposures Political Product Safety
News headline image
Why Amylyx Pharmaceuticals Stock Skyrocketed Today ↗
Via The Motley Fool
Tickers AMLX
Exposures Product Safety
News headline image
Kaplan Fox & Kilsheimer LLP Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Mineralys (MLYS) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers MLYS
Exposures Financial Product Safety
News headline image
Taysha Gene Therapies (TSHA) Q2 2026 Earnings Call ↗
Via The Motley Fool
Tickers TSHA
Exposures Product Safety
News headline image
Kaplan Fox is Investigating Potential Securities Law Violations Against Medline Inc. (NASDAQ: MDLN)
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations
Via NewMediaWire
Tickers FULC
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.